» Articles » PMID: 22850425

Kinetic Signatures of MicroRNA Modes of Action

Overview
Journal RNA
Specialty Molecular Biology
Date 2012 Aug 2
PMID 22850425
Citations 56
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs (miRNAs) are key regulators of all important biological processes, including development, differentiation, and cancer. Although remarkable progress has been made in deciphering the mechanisms used by miRNAs to regulate translation, many contradictory findings have been published that stimulate active debate in this field. Here we contribute to this discussion in three ways. First, based on a comprehensive analysis of the existing literature, we hypothesize a model in which all proposed mechanisms of microRNA action coexist, and where the apparent mechanism that is detected in a given experiment is determined by the relative values of the intrinsic characteristics of the target mRNAs and associated biological processes. Among several coexisting miRNA mechanisms, the one that will effectively be measurable is that which acts on or changes the sensitive parameters of the translation process. Second, we have created a mathematical model that combines nine known mechanisms of miRNA action and estimated the model parameters from the literature. Third, based on the mathematical modeling, we have developed a computational tool for discriminating among different possible individual mechanisms of miRNA action based on translation kinetics data that can be experimentally measured (kinetic signatures). To confirm the discriminatory power of these kinetic signatures and to test our hypothesis, we have performed several computational experiments with the model in which we simulated the coexistence of several miRNA action mechanisms in the context of variable parameter values of the translation.

Citing Articles

MicroRNA Nobel Prize: Timely Recognition and High Anticipation of Future Products-A Prospective Analysis.

Niazi S, Magoola M Int J Mol Sci. 2024; 25(23.

PMID: 39684593 PMC: 11641023. DOI: 10.3390/ijms252312883.


Translational modeling-based evidence for enhanced efficacy of standard-of-care drugs in combination with anti-microRNA-155 in non-small-cell lung cancer.

Dogra P, Shinglot V, Ruiz-Ramirez J, Cave J, Butner J, Schiavone C Mol Cancer. 2024; 23(1):156.

PMID: 39095771 PMC: 11295620. DOI: 10.1186/s12943-024-02060-5.


Translational modeling-based evidence for enhanced efficacy of standard-of-care drugs in combination with anti-microRNA-155 in non-small-cell lung cancer.

Dogra P, Shinglot V, Ruiz-Ramirez J, Cave J, Butner J, Schiavone C medRxiv. 2024; .

PMID: 38559070 PMC: 10980136. DOI: 10.1101/2024.03.14.24304306.


An integrated study of glutamine alleviates enteritis induced by glycinin in hybrid groupers using transcriptomics, proteomics and microRNA analyses.

He Y, Dong X, Yang Q, Liu H, Zhang S, Xie S Front Immunol. 2023; 14:1301033.

PMID: 38077360 PMC: 10702536. DOI: 10.3389/fimmu.2023.1301033.


MicroRNA Profiling of Red Blood Cells for Lung Cancer Diagnosis.

Geng X, Ma J, Dhilipkannah P, Jiang F Cancers (Basel). 2023; 15(22).

PMID: 38001571 PMC: 10670279. DOI: 10.3390/cancers15225312.


References
1.
Aleman L, Doench J, Sharp P . Comparison of siRNA-induced off-target RNA and protein effects. RNA. 2007; 13(3):385-95. PMC: 1800510. DOI: 10.1261/rna.352507. View

2.
Zinovyev A, Morozova N, Nonne N, Barillot E, Harel-Bellan A, Gorban A . Dynamical modeling of microRNA action on the protein translation process. BMC Syst Biol. 2010; 4:13. PMC: 2847993. DOI: 10.1186/1752-0509-4-13. View

3.
Yang E, van Nimwegen E, Zavolan M, Rajewsky N, Schroeder M, Magnasco M . Decay rates of human mRNAs: correlation with functional characteristics and sequence attributes. Genome Res. 2003; 13(8):1863-72. PMC: 403777. DOI: 10.1101/gr.1272403. View

4.
Thermann R, Hentze M . Drosophila miR2 induces pseudo-polysomes and inhibits translation initiation. Nature. 2007; 447(7146):875-8. DOI: 10.1038/nature05878. View

5.
Chendrimada T, Finn K, Ji X, Baillat D, Gregory R, Liebhaber S . MicroRNA silencing through RISC recruitment of eIF6. Nature. 2007; 447(7146):823-8. DOI: 10.1038/nature05841. View